Both in Pharmaceuticals
Viridian Therapeutics vs Dyne Therapeutics
Over the past year VRDN returned +9.3% and DYN returned −28.2%; their daily moves had a correlation of 0.25.
VRDN +9.3% DYN −28.2%Growth of $1, one year, split-adjusted
| Metric | VRDN | DYN |
|---|---|---|
| Price | $25.30 | $17.30 |
| Market cap | $2.87B | $3.23B |
| Today | +2.55% | +3.65% |
| 1 month | +30.4% | +13.8% |
| 6 months | +79.9% | −2.3% |
| Year to date | −18.7% | −11.6% |
| 1 year | +6.9% | −26.5% |
| Revenue growth (YoY) | +278.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −39726.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 40.3× | — |
| Net cash | $625.7M | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 47.5% | 58.7% |
| Short % of float | 18.5% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).